Navigation Links
NJLRA Statement in Response to Roche's Discontinuation of Accutane(R)
Date:6/26/2009

TRENTON, N.J., June 26 /PRNewswire/ -- Marcus Rayner, executive director of the New Jersey Lawsuit Reform Alliance, a statewide, bipartisan group of individuals, businesses and organizations dedicated to improving the state's civil justice system and advocating for legal reform in the legislature and in the courts, today issued the following statement in reaction to Roche's announcement that the company will immediately discontinue Accutane(R), a treatment for severe acne:

"Thanks to an aggressive, self-interested campaign by personal injury lawyers, an important medical breakthrough deemed safe and effective by the U.S. Food and Drug Administration and that helped more than 13 million patients treat severe acne was voluntarily removed from the market today by the manufacturer. This leaves millions of patients around the world with fewer treatment options.

"New Jersey companies lead the world in discovering medical innovations like Accutane(R), which have improved the quality of life of millions. But the high cost of frivolous lawsuits -- like the Accutane(R) cases being tried in New Jersey -- threatens medical progress.

"The trial bar shouldn't leave patients out in the cold. NJLRA will continue to fight for common sense reforms that improve our courts and protect patients."

    Contact: Marcus Rayner
    (609) 651-3774
    mrayner@njlra.org


'/>"/>
SOURCE New Jersey Lawsuit Reform Alliance
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. NJLRA Statement on Todays U.S. Supreme Courts Decision in Wyeth v. Levine
2. AAHSA Statement on Long-Term Services and Supports CBO Scoring
3. AAHSA Statement on House Ways and Means Committee Hearing
4. Statement of Dr. Elena Rios, MD, MSPH, President and CEO, National Hispanic Medical Association
5. Phyhealth Issues 2008 Audited Financial Statements and Provides Business Update
6. Pelosi Statement on President Obama Signing Smoking Prevention and Tobacco Control Act
7. PhRMA Statement on Medicare Part D Coverage Gap
8. Pelosi Statement on House Committee Chairmens Draft Health Care Reform Proposal
9. Wyeth Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
10. National Changing Diabetes Program Issues Statement on President Obamas Speech to the American Medical Association
11. Statement of James P. Firman President and CEO, National Council on Aging on World Elder Abuse Awareness Day June 15, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... Adolfson & Peterson Construction (AP) ... Ramsey County Medical Examiners Facility located in Saint Paul, Minn. A single story, ... scheduled to start in late 2017/early 2018. , Staffed by 20 full-time ...
(Date:7/21/2017)... ... July 21, 2017 , ... The Margarian Law Firm has filed a ... its ginger ale for allegedly containing no ginger. Dr. Pepper produces the “Canada Dry” ... plaintiff Gegham Margaryan alleges Canada Dry Ginger Ale claims on its bottle that it ...
(Date:7/21/2017)... OR (PRWEB) , ... July 21, 2017 , ... ... recent weeks Nature’s Tears® EyeMist®, the signature product of her research center at ... with the world’s largest population and the greatest number of sufferers of blindness. ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... TransPixel Volume ... between two clips in the FCPX timeline. This effect isolates horizontal and vertical lines ... this package contains either a rotating or flipping animation and can be changed using ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/1/2017)... Ind. , June 30, 2017 Zimmer Biomet ... quarter sales and earnings conference call will be broadcast live ... a.m. Eastern Time.  A news release detailing the quarterly results ... morning of the conference call. The live audio ... at http://investor.zimmerbiomet.com . It will be archived for replay ...
(Date:6/30/2017)...  Axium Pharmaceuticals Inc. is a pharmaceutical company aimed at utilizing ... dosage forms of existing biologically active molecule. ... Subveta oral ... emulsifying formula, which is designed to prevent precipitation of the ... will provide fast onset of action and is designed to ...
(Date:6/20/2017)... LAGUNA HILLS, Calif. , June 20, 2017 /PRNewswire/ ... validate the use of MMprofiler with SKY92, the company,s ... (MM). In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will ... elderly patients. In a separate e-poster ...
Breaking Medicine Technology: